Clinical trial The APOLLO Study
A phase III Study comparing Pomalidomide and Dexamethasone with or without Daratumumab in Subjects with Relapsed or Refractory Multiple Myeloma who have received at least one prior line of therapy with both Lenalidomide and a Proteasome Inhibitor
Cancers | |
---|---|
Organ | Myeloma |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | EMN |
EudraCT Identifier | 2017-001618-27 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03180736 |
Inclusion criteria | - prior anti-myeloma treatment included both a PI- and lenalidomide-containing regimens- no previous therapy with Pomalidomide nor CD-38 MoAb |
Last update |